Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations

References

• Salam MA, Al-Amin MY, Salam MT, et al. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare. 2023 Jul 5;11(13):1946. doi: 10.3390/healthcare11131946
   Web of Science ®Google Scholar
• WHO. Antimicrobial Resistance 2021. [cited 2023 Aug 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
   Google Scholar
• Karanika S, Paudel S, Grigoras C, et al. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of Hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016 Aug;60(8):4840–4852.
   PubMed Web of Science ®Google Scholar
• Mendelson M, Morris AM, Thursky K, et al. How to start an antimicrobial stewardship programme in a hospital. Clin Microbiol Infect. 2020 Apr;26(4):447–453.
   PubMed Web of Science ®Google Scholar
• Truong WR, Yamaki J. The Hospital antimicrobial use process: from beginning to end. Open Forum Infect Dis. 2018 Jun;5(6):ofy098. doi: 10.1093/ofid/ofy098
   PubMed Web of Science ®Google Scholar
• WHO. Antimicrobial stewardship programmes in Health-care facilities in low- and middle-income countries a WHO practical toolkit 2019 [cited 2022 Aug 4]. Available from: https://apps.who.int/iris/bitstream/handle/10665/329404/9789241515481-eng.pdf
   Google Scholar
• Akinboyo IC, Gerber JS. Principles, policy and practice of antibiotic stewardship. Semin Perinatol. 2020 Dec;44(8):151324. doi: 10.1016/j.semperi.2020.151324
   PubMed Web of Science ®Google Scholar
• Dellit TH, Owens RC, McGowan JE Jr., et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007 Jan 15;44(2):159–177. doi: 10.1086/510393
   PubMed Web of Science ®Google Scholar
• Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017 Apr;38(2):59–68. doi: 10.1515/cclm-2016-0705
   PubMedGoogle Scholar
• Kyriazopoulou E, Giamarellos-Bourboulis EJ. Antimicrobial stewardship using biomarkers: accumulating Evidence for the critically ill. Antibiotics. 2022 Mar 9;11(3):367. doi: 10.3390/antibiotics11030367
   Google Scholar
• Bartoletti M, Antonelli M, Bruno Blasi FA, et al. Procalcitonin-guided antibiotic therapy: an expert consensus. Clin Chem Lab Med. 2018 Jul 26;56(8):1223–1229. doi: 10.1515/cclm-2018-0259
   PubMed Web of Science ®Google Scholar
• Rhee C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis. 2017 r;4(1):ofw249. Winte. doi: 10.1093/ofid/ofw249
   PubMed Web of Science ®Google Scholar
• Bowman C, Covington EW. Determination of the optimal procalcitonin threshold for infection in patients with impaired renal function at a community Hospital. J Pharm Technol. 2020 Aug;36(4):157–163. doi: 10.1177/8755122520924803
   PubMed Web of Science ®Google Scholar
• Yunus I, Fasih A, Wang Y, et al. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018;13(11):e0206527. doi: 10.1371/journal.pone.0206527
   PubMed Web of Science ®Google Scholar
• Pokharel S, Adhikari B. Antimicrobial resistance and over the counter use of drugs in Nepal. J Glob Health. 2020 Jun;10(1):010360. doi: 10.7189/jogh.10.010360
   PubMed Web of Science ®Google Scholar
• Hey J, Thompson-Leduc P, Kirson NY, et al. Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis. Clin Chem Lab Med. 2018;56(8):1200–1209. doi: 10.1515/cclm-2018-0126
   PubMed Web of Science ®Google Scholar
• Macfarlane J, Lewis SA, Macfarlane R, et al. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management guidelines. Respir med. 1997 Aug;91(7):427–434.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009 Sep 9;302(10):1059–1066. doi: 10.1001/jama.2009.1297
   PubMed Web of Science ®Google Scholar
• Meisner M. Procalcitponin: Biochemistry and Clinical Diagnosis. Bremen (DE): UNI-MED; 2010 .
   Google Scholar
• Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019 Aug 27;57(9):1308–1318. doi: 10.1515/cclm-2018-1181
   PubMed Web of Science ®Google Scholar
• Li Z, Yuan X, Yu L, et al. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: an updated meta-analysis. Medicine. 2019;98(32):e16775. doi: 10.1097/MD.0000000000016775
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004 Feb 21;363(9409):600–607. doi: 10.1016/S0140-6736(04)15591-8
   PubMed Web of Science ®Google Scholar
• Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections‐Full version. Clin Microbiol Infect. 2011;17:E1–E59. doi: 10.1111/j.1469-0691.2011.03672.x
   PubMed Web of Science ®Google Scholar
• Broyles MR. Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence. Open Forum Infect Dis. 2017 Fall;4(4):ofx213. doi: 10.1093/ofid/ofx213
   PubMed Web of Science ®Google Scholar
• Meier MA, Branche A, Neeser OL, et al. Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clin Infect Dis. 2019;69(3):388–396. doi: 10.1093/cid/ciy917
   PubMed Web of Science ®Google Scholar
• Oliveira CF, Botoni FA, Oliveira CR, et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med. 2013 Oct;41(10):2336–2343.
   PubMed Web of Science ®Google Scholar
• Wirz Y, Meier MA, Bouadma L, et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care. 2018 Aug 15;22(1):191. doi: 10.1186/s13054-018-2125-7
   PubMedGoogle Scholar
• de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016 Jul;16(7):819–827.
   PubMed Web of Science ®Google Scholar
• Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, et al. Procalcitonin to reduce Long-term infection-associated adverse events in sepsis. A randomized trial. Am J Respir Crit Care Med. 2021 Jan 15;203(2):202–210. doi: 10.1164/rccm.202004-1201OC
   PubMed Web of Science ®Google Scholar
• Fugit RV, McCoury JB, Bessesen MT. Procalcitonin for sepsis management: implementation within an antimicrobial stewardship program. Am J Health Syst Pharm. 2023 May 24;80(Suppl 2):S49–S54. doi: 10.1093/ajhp/zxac341
   PubMedGoogle Scholar
• Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010 Feb 6;375(9713):463–474. doi: 10.1016/S0140-6736(09)61879-1
   PubMed Web of Science ®Google Scholar
• Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock–a systematic review and meta-analysis. Crit Care. 2013 Dec 11;17(6):R291. doi: 10.1186/cc13157
   PubMed Web of Science ®Google Scholar
• Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018 Jan;18(1):95–107.
   PubMed Web of Science ®Google Scholar
• Stocker M, Fontana M, El Helou S, et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97(2):165–174. doi: 10.1159/000241296
   PubMed Web of Science ®Google Scholar
• Huang HB, Peng JM, Weng L, et al. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis. Ann Intensive Care. 2017 Nov 22;7(1):114. doi: 10.1186/s13613-017-0338-6
   PubMedGoogle Scholar
• Li S, Rong H, Guo Q, et al. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016;21(1):39. doi: 10.4103/1735-1995.183996
   PubMedGoogle Scholar
• Sathitakorn O, Chansirikarnjana S, Jantarathaneewat K, et al. The role of procalcitonin and clinical pulmonary for infection score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: a quasi-experimental multicenter study. Infect Control Hosp Epidemiol. 2022 Aug;22(7):1–5.
   Google Scholar
• Sathitakorn O, Jantarathaneewat K, Weber DJ, et al. The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: a pilot study. Am J Infect Control. 2022 May;50(5):581–584.
   PubMed Web of Science ®Google Scholar
• Calderon-Parra J, Muino-Miguez A, Bendala-Estrada AD, et al. Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One. 2021;16(5):e0251340. doi: 10.1371/journal.pone.0251340
   PubMed Web of Science ®Google Scholar
• Heesom L, Rehnberg L, Nasim-Mohi M. et al. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit. J Glob Antimicrob Resist. 2020 Sep;22:782–784.
   PubMed Web of Science ®Google Scholar
• Fartoukh M, Nseir S, Megarbane B, et al. Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial. Clin Microbiol Infect. 2023 Jun;29(6):734–743.
   PubMed Web of Science ®Google Scholar
• El Haddad H, Chaftari AM, Hachem R, et al. Author correction: procalcitonin guiding antimicrobial therapy duration in febrile cancer patients with documented infection or neutropenia. Sci Rep. 2018 Apr 19;8(1):6258. doi: 10.1038/s41598-018-24172-x
   PubMedGoogle Scholar
• Liew Y, Lee W, Cai Y, et al. Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies. Eur J Clin Microbiol Infect Dis. 2012;31(11):3041–3046. doi: 10.1007/s10096-012-1662-2
   PubMed Web of Science ®Google Scholar
• Dagher H, Chaftari A-M, Hachem RY, et al. editors. 356. The role of procalcitonin in antimicrobial stewardship among cancer patients admitted with COVID-19. Open Forum Infect Dis. 2021;8(Supplement_1):S282–S282. Oxford University Press. doi: 10.1093/ofid/ofab466.557
   Google Scholar
• Jaresova M, Striz I, Cermakova J, et al. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol Lett. 1999 Sep 1;69(3):355–358. doi: 10.1016/S0165-2478(99)00120-0
   PubMed Web of Science ®Google Scholar
• Yu XY, Wang Y, Zhong H, et al. Diagnostic value of serum procalcitonin in solid organ transplant recipients: a systematic review and meta-analysis. Transplant Proc. 2014 Jan;46(1):26–32.
   PubMed Web of Science ®Google Scholar
• Chae H, Bevins N, Seymann GB, et al. Diagnostic Value of Procalcitonin in Transplant Patients Receiving Immunosuppressant Drugs: A Retrospective Electronic Medical Record-Based Analysis. Am J Clin Pathol. 2021 Nov 8;156(6):1083–1091. doi: 10.1093/ajcp/aqab077
   PubMed Web of Science ®Google Scholar
• Howard P, Pulcini C, Levy Hara G, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015 Apr;70(4):1245–1255.
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Kwa AL, Chiu CH, et al. Antimicrobial stewardship for acute-care hospitals: An Asian perspective. Infect Control Hosp Epidemiol. 2018 Oct;39(10):1237–1245.
   PubMed Web of Science ®Google Scholar
• Malan L, Labuschagne Q, Brechtelsbauer E, et al. Sustainable access to antimicrobials; a missing component to antimicrobial stewardship-A Tale of two countries. Front Public Health. 2018;6:324. doi: 10.3389/fpubh.2018.00324
   PubMed Web of Science ®Google Scholar
• Lee CC, Kwa ALH, Apisarnthanarak A, et al. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. Clin Chem Lab Med. 2020 Nov 26;58(12):1983–1991. doi: 10.1515/cclm-2019-1122
   PubMed Web of Science ®Google Scholar
• Cleland DA, Eranki AP. Procalcitonin. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Ambika Eranki declares no relevant financial relationships with ineligible companies.2023.
   Google Scholar
• Shehabi Y, Sterba M, Garrett PM, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med. 2014 Nov 15;190(10):1102–1110. doi: 10.1164/rccm.201408-1483OC
   PubMed Web of Science ®Google Scholar
• Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011 Sep 22;9(1):107. doi: 10.1186/1741-7015-9-107
   PubMedGoogle Scholar
• Liew YX, Chlebicki MP, Lee W, et al. Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP). Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):853–855.
   PubMed Web of Science ®Google Scholar
• Khawcharoenporn T, Apisarnthanarak A, Mundy LM. National survey of antimicrobial stewardship programs in Thailand. Am J Infect Control. 2013 Jan;41(1):86–88. doi: 10.1016/j.ajic.2012.01.032
   PubMed Web of Science ®Google Scholar
• Huong VTL, Ngan TTD, Thao HP, et al. Assessing feasibility of establishing antimicrobial stewardship programmes in two provincial-level hospitals in Vietnam: an implementation research study. BMJ Open. 2021 Oct 1;11(10):e053343. doi: 10.1136/bmjopen-2021-053343
   PubMed Web of Science ®Google Scholar
• Limato R, Lazarus G, Dernison P, et al. Optimizing antibiotic use in Indonesia: a systematic review and evidence synthesis to inform opportunities for intervention. Lancet Reg Health Southeast Asia. 2022may;2(100013). doi: 10.1016/j.lansea.2022.05.002
   PubMedGoogle Scholar
• Sumpradit N, Wongkongkathep S, Malathum K, et al. Thailand’s national strategic plan on antimicrobial resistance: progress and challenges. Bull World Health Organ. 2021 Sep 1;99(9):661–673. doi: 10.2471/BLT.20.280644
   PubMed Web of Science ®Google Scholar
• MOH. One Health report on antimicrobial utilisation and resistance. 2019; 1–67 [cited 2022 Nov 10]. Available from: https://www.moh.gov.sg/docs/librariesprovider5/resources-statistics/reports/one-health-report-on-antimicrobial-utilisation-and-resistance-2019.pdf
   Google Scholar
• Chandy S, Michael J, Veeraraghavan B, et al. ICMR programme on antibiotic stewardship, prevention of infection & control (ASPIC). Indian J Med Res. 2014 Feb 01;139(2):226–230.
   PubMedGoogle Scholar
• Williams EJ, Mair L, de Silva TI, et al. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study. J Hosp Infect. 2020;110 :103–107. doi: 10.1016/j.jhin.2021.01.006
   Web of Science ®Google Scholar
• Huttner BD, Catho G, Pano-Pardo JR, et al. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020 Jul;26(7):808–810.
   PubMed Web of Science ®Google Scholar
• Wolfisberg S, Gregoriano C, Schuetz P. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19. Crit Rev Clin Lab Sci. 2022 Jan;59(1):54–65. doi: 10.1080/10408363.2021.1975637
   PubMed Web of Science ®Google Scholar
• Hughes S, Mughal N, Moore LSP. Procalcitonin to guide antibacterial prescribing in patients hospitalised with COVID-19. Antibiotics. 2021;10(9):1119. doi: 10.3390/antibiotics10091119
   Web of Science ®Google Scholar
• Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011 Aug 8;171(15):1322–1331. doi: 10.1001/archinternmed.2011.318
   PubMedGoogle Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive care Med. 2021 Nov;47(11):1181–1247.
   PubMed Web of Science ®Google Scholar
• Pepper DJ, Sun J, Rhee C, et al. Procalcitonin-guided antibiotic discontinuation and mortality in critically ill adults: a systematic review and meta-analysis. Chest. 2019 Jun;155(6):1109–1118.
   PubMed Web of Science ®Google Scholar
• Cole JL. Implementation of the Procalcitonin Assay in a Rural Hospital. Hosp Pharm. 2018 Dec;53(6):395–402. doi: 10.1177/0018578718762128
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, et al. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev. 2017 Jan;26(143):160073.
   PubMed Web of Science ®Google Scholar
• Yan ST, Zhang G. Diagnostic and predictive values of procalcitonin in bloodstream infections for nosocomial pneumonia. J Crit Care. 2018 Oct;47:346–347. doi: 10.1016/j.jcrc.2018.05.010
   PubMed Web of Science ®Google Scholar
• Hoeboer SH, van der Geest PJ, Nieboer D, et al. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015 May;21(5):474–481.
   PubMed Web of Science ®Google Scholar
• Daubin C, Valette X, Thiolliere F, et al. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study. Intensive care Med. 2018 Apr;44(4):428–437.
   PubMed Web of Science ®Google Scholar
• Goodlet KJ, Cameron EA, Nailor MD. Low sensitivity of procalcitonin for bacteremia at an Academic Medical center: a cautionary tale for antimicrobial stewardship. Open Forum Infect Dis. 2020 Apr;7(4):ofaa096. doi: 10.1093/ofid/ofaa096
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45–e67. doi: 10.1164/rccm.201908-1581ST
   PubMed Web of Science ®Google Scholar
• Ito A, Ishida T. Diagnostic markers for community-acquired pneumonia. Ann Transl Med. 2020 May;8(9):609. doi: 10.21037/atm.2020.02.182
   PubMed Web of Science ®Google Scholar
• Grace E, Turner RM. Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis. 2014 Dec 15;59(12):1761–1767. doi: 10.1093/cid/ciu732
   PubMed Web of Science ®Google Scholar
• Morgan JE, Phillips B. PAnTher cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study. BMJ Paediatr Open. 2022 Mar;6(1):e001339. doi: 10.1136/bmjpo-2021-001339
   PubMedGoogle Scholar
• Waldron CA, Thomas-Jones E, Bernatoniene J, et al. Biomarker-guided duration of antibiotic treatment in Children hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial. BMJ Open. 2022 Jan 25;12(1):e047490. doi: 10.1136/bmjopen-2020-047490
   PubMedGoogle Scholar
• Veepanattu P, Singh S, Mendelson M, et al. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK. Int J Infect Dis. 2020 Nov;100:278–282.
   PubMed Web of Science ®Google Scholar
• Takamatsu A, Yao K, Murakami S, et al. Barriers to Adherence to Antimicrobial Stewardship Postprescription Review and Feedback For Broad-Spectrum Antimicrobial Agents: A Nested Case-Control Study. Open Forum Infect Dis. 2020 Aug;7(8):ofaa298.
   PubMed Web of Science ®Google Scholar
• van der Velden LB, Tromp M, Bleeker-Rovers CP, et al. Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1561–1568.
   PubMed Web of Science ®Google Scholar
• Lam SW, Bauer SR, Fowler R, et al. Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on Subgroups based on antibiotic initiation, cessation, or mixed strategies. Crit Care Med. 2018 May;46(5):684–690.
   PubMed Web of Science ®Google Scholar
• Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018 Jul 19 ;379(84):236–249. doi: 10.1056/NEJMoa1802670
   PubMedGoogle Scholar
• Kip MMA, van Oers JA, Shajiei A, et al. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands. Crit Care. 2018 Nov 13;22(1):293. doi: 10.1186/s13054-018-2234-3
   PubMedGoogle Scholar
• Collins CD, Brockhaus K, Sim T, et al. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis. Am J Health Syst Pharm. 2019 Aug 1;76(16):1219–1225. doi: 10.1093/ajhp/zxz129
   PubMed Web of Science ®Google Scholar
• Mewes JC, Pulia MS, Mansour MK, et al. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: a health economic model analysis. PLoS One. 2019;14(4):e0214222. doi: 10.1371/journal.pone.0214222
   PubMed Web of Science ®Google Scholar
• Dx N. IB10 sphingotest PCT 2020. [cited 2023 Aug 25]. Available from: https://www.nexus-dx.com/products/ib10-sphingotest-pct/
   Google Scholar
• Radiometer. Radiometer India launches new point-of-care test for procalcitonin, aiding diagnosis of sepsis 2015. [cited 2023 Aug 25] Available from: https://www.radiometer.in/en-in/about-radiometer/news/radiometer-launches-new-point-of-care-test-for-procalcitonin
   Google Scholar
• Sphingotech. The biomarker company. [cited 2023 Aug 25]. Available from: https://sphingotec.com/fileadmin/user_upload/WE-EN-M4F-IMG_02_Image_Broschure_English_web.pdf
   Google Scholar